Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Controlled drugs

NICE issues guidance to improve controlled drug safety

The National Institute for Health and Care Excellence (NICE) has published a guideline on the management of controlled drugs.

The guideline calls on NHS organisations to develop a controlled-drugs policy and standard operating procedures for storing, transporting, destroying and disposing of controlled drugs.

It also recommends that healthcare professionals advise patients on how to store and dispose of their medications and discuss with them whether the drugs will be accessible to others. Pharmacists should take reasonable steps to confirm the identity of a person collecting a prescription for a controlled drug and explain to patients or carers that the drugs should only be used by the person named on the prescription.

The guideline also states that the supply of controlled drugs should not exceed 30 days, unless there are exceptional circumstances.

NICE created the guidance to bring together legislation changes with current policy and best practice advice. It says the guidance should give greater clarity to healthcare professionals, help organisations to ensure working practices comply with legislation, and reduce the safety risks associated with controlled drugs.

“A great deal of work has been done recently to help ensure the safe use and management of controlled drugs at a local and national level,” says GP Tessa Lewis, who chaired the guideline development group. “However, ongoing activity and vigilance is required to sustain the positive developments that have been achieved since the changes to the structure of the NHS took effect in 2012.”

A study of data from 2005 to 2011 found that controlled drugs accounted for the majority of serious harm from medication incidents reported in England and Wales.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201007

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • MCQs in Clinical Pharmacy

    MCQs in Clinical Pharmacy

    Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.

    £25.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • National Institute for Health and Care Excellence (NICE) office signage

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.